SELECTIS HEALTH, INC. 8-K

What Happened Selectis Health, Inc. (GBCS) announced that Adam Desmond resigned from all roles with the company — including CEO, CFO, and member of the Board — effective May 14, 2026. A Separation Agreement and Release has been executed and is filed as Exhibit 10.1 to the 8-K. On May 15, 2026, the Board appointed Krystal Eckhart, previously a Vice President at the company, as Interim CEO and Interim CFO.

Key Details

• Resignation date: Adam Desmond resigned effective May 14, 2026 (Item 5.02 disclosure).
• Interim appointment: Krystal Eckhart named Interim CEO and Interim CFO on May 15, 2026.
• Separation agreement: A Separation Agreement and Release has been signed and is filed as Exhibit 10.1.
• Eckhart background: Age 41; 15+ years in healthcare revenue cycle and financial ops; with Selectis since 2016; currently VP of Revenue Management overseeing Medicare/Medicaid operations for 9 multi-state facilities, SEC audits, financial reporting, AR/AP, and acquisition-related financial processes.

Why It Matters A simultaneous CEO and CFO departure is a material leadership change that can affect company strategy, investor confidence, and financial oversight. The board’s internal appointment of a revenue and finance-focused executive suggests continuity in financial operations and revenue-cycle management, but the separation agreement and interim status indicate further updates (permanent replacement or terms) may follow. Investors should watch for subsequent disclosures about any financial terms of the separation, changes in governance, and plans for a permanent CEO/CFO.